Skip to main content

Table 3 Attitudes, practices and opinion of midwives toward cervical cancer prevention by category of health facility, Abidjan, Côte d’Ivoire, 2012

From: Cervical cancer prevention in reproductive health services: knowledge, attitudes and practices of midwives in Côte d’Ivoire, West Africa

 

Total

UH

GH

PHC

P

SoM

P*

 

N = 592 (%)

n = 125 (%)

n = 134 (%)

n = 194 (%)

 

n = 139 (%)

 

Midwives screened

112 (18.9)

39 (31.2)

26 (19.4)

32 (16.5)

<0.01

15 (10.8)

<0.01

Type of test (N = 112)

    

NA

 

NA

Pap smear

80 (13.5)

29 (74.4)

19 (73.1)

27 (84.4)

 

5 (33.3)

 

VIA

29 (4.9)

8 (20.5)

7 (26.9)

5 (15.6)

 

9 (60.0)

 

Ignore it**

3 (2.7)

2 (5.1)

0 (0.0)

0 (0.0)

 

1 (6.7)

 

Practice of screening

       

Propose screening to women

223 (37.7)

57 (45.6)

62 (46.3)

53 (27.3)

<0.01

51 (36.7)

<0.01

Had already performed visual inspection

50 (8.4)

12 (9.6)

16 (11.9)

11 (5.7)

0.12

11 (7.9)

0.22

Opinion on the HPV vaccine (N = 298)

       

Protect against cervical cancer

224 (75.2)

64 (80.0)

47 (79.7)

75 (81.5)

0.01

38 (56.7)

<0.01

Available in Côte d’Ivoire

158 (53.0)

42 (52.5)

39 (66.1)

47 (51.1)

0.12

30 (44.8)

0.11

Dangerous for health

10 (3.4)

2 (2.5)

3 (5.1)

4 (4.3)

NA

1 (1.5)

NA

Expensive

8 (2.7)

2 (2.5)

2 (3.4)

3 (3.3)

NA

1 (1.5)

NA

Will recommend it

211 (70.8)

59 (73.8)

45 (76.3)

74 (80.4)

0.10

33 (49.3)

<0.01

  1. UH: University Hospital; GH: General Hospital; PHC: Primary Health Center; SoM: School of Midwifery; p: comparison of responses between UH, GH and PHC (student excluded). P*: comparison of the four groups of midwives. Ignore it**: respondents report that the test was neither pap smear nor VIA, but were unable to remember the name of the screening test they benefited from. NA: Chi2 test Not Applicable.